Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Assessment of iCare RETCAD as an Automated Tool for Diabetic Retinopathy Screening

NCT07404657 is registered in ClinicalTrials.gov with Centervue SpA as lead sponsor.

NCT NCT07404657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07404657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Assessment of iCare RETCAD as an Automated Tool for Diabetic Retinopathy Screening
Lead sponsor
Centervue SpA
Phase
Observational
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
April 30, 2026
Enrollment
198 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy (dr)